HHS and CMS have eliminated health insurance subsidies for 189,000 duplicate and ineligible enrollees following an ongoing federal audit.
HHS Cuts Health Insurance Subsidies for 189K Enrollees Read More
European automakers like Volkswagen, Stellantis, and Renault are leaning into retro designs and strategic overhauls to rival affordable Chinese EVs.
European Automakers Embrace Retro Design to Fight Chinese EVs Read More
Scientists have identified a new dinosaur species, a tiger-sized T. rex cousin named Invictibellatrix amberina, from a fossil overlooked for a century.
New Dinosaur Species Discovered After Sitting in Museum Drawer for 100 Years Read More
The CDC has set aside $1.6 million to help fund a controversial hepatitis B vaccine trial in Guinea-Bissau, sparking widespread ethics concerns.
CDC Moves Forward With Controversial Guinea-Bissau Vaccine Trial Read More
HHS and CMS have eliminated federal health insurance subsidies for 189,000 duplicate or deceased enrollees as part of an ongoing audit to curb waste.
HHS Cuts Health Insurance Subsidies for 189K Duplicate Enrollees Read More
Volkswagen, Stellantis, and Renault are rethinking their EV strategies and pushing for stricter local-content thresholds to combat rising Chinese competition.
VW, Stellantis and Renault Shift Strategy Against Chinese EVs Read More
Dallas-based biotech firm Colossal Biosciences reveals its newest de-extinction target: the bluebuck antelope, alongside updates on woolly mammoth and dodo projects.
Colossal Biosciences Adds Bluebuck Antelope to De-Extinction Roster Read More
Mercedes-Benz is expanding its safety recall to cover over 30,000 S-Class, Maybach, and AMG vehicles due to potentially leaking front brake hoses.
Mercedes-Benz Expands Brake Hose Recall to Over 30,000 S-Class Cars Read More
European automakers like Volkswagen, Mercedes, and Renault face intense market pressure, increasing defense contracts, and rising Chinese competition.
European Automakers Face Enormous Pressure Amid Industry Shifts Read More
Conflicting reports emerge over the cancellation of a controversial U.S.-funded hepatitis B newborn vaccine trial in Guinea-Bissau.
Confusion Surrounds Controversial Guinea-Bissau Vaccine Trial Read More